Literature DB >> 21678398

Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.

Inger T Gram1, Annekatrin Lukanova, Ilene Brill, Tonje Braaten, Eiliv Lund, Eva Lundin, Kim Overvad, Anne Tjønneland, Francoise Clavel-Chapelon, Nathalie Chabbert-Buffet, Christina Bamia, Antonia Trichopoulou, Dimosthenis Zylis, Giovanna Masala, Franco Berrino, Rocco Galasso, Rosario Tumino, Carlotta Sacerdote, Oxana Gavrilyuk, Steinar Kristiansen, Laudina Rodríguez, Catalina Bonet, José María Huerta, Aurelio Barricarte, Maria-José Sánchez, Miren Dorronsoro, Karin Jirström, Martin Almquist, Annika Idahl, H Bas Bueno-de-Mesquita, Marie Braem, Charlotte Onland-Moret, Konstantinos K Tsilidis, Naomi E Allen, Veronika Fedirko, E Riboli, Rudolf Kaaks.   

Abstract

New data regarding a positive association between smoking and risk of epithelial ovarian cancer (EOC), especially the mucinous tumor type, has started to emerge. The purpose of this study was to examine the association between different measures of smoking exposures and subtypes of EOC in a large cohort of women from 10 European countries. The European Prospective Investigation into Cancer and Nutrition (EPIC) cohort is a multicenter prospective study initiated in 1992. The questionnaires included data about dietary, lifestyle, and health factors. Information about cigarette smoking was collected from individuals in all participating countries. We used Cox proportional hazard regression models to estimate hazard ratio (HR) of EOC overall and serous, mucinous, and endometroid histological subtypes, with 95% confidence intervals (CIs) associated with different measures of smoking exposures adjusting for confounding variables. Altogether 836 incident EOC cases were identified among 326,831 women. The tumors were classified as 400 serous, 83 mucinous, 80 endometroid, 35 clear cell, and 238 unspecified. Compared with never smokers, current smokers had a significantly increased risk for mucinous tumors [HR = 1.85 (95% CI 1.08-3.16)] and those smoking more than 10 cigarettes per day had a doubling in risk [HR = 2.25(95% CI 1.26-4.03)] as did those who had smoked less than 15 pack-years of cigarettes [HR = 2.18 (95% CI 1.07-4.43)]. The results from the EPIC study add further evidence that smoking increases risk of mucinous ovarian cancer and support the notion that the effect of smoking varies according to histological subtype.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21678398     DOI: 10.1002/ijc.26235

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.

Authors:  Rhonda Arthur; Theodore M Brasky; Tracy E Crane; Ashley S Felix; Andrew M Kaunitz; Aladdin H Shadyab; Lihong Qi; Sylvia Wassertheil-Smoller; Thomas E Rohan
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

2.  High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.

Authors:  Lauren C Peres; Adrianne R Mallen; Mary K Townsend; Elizabeth M Poole; Britton Trabert; Naomi E Allen; Alan A Arslan; Laure Dossus; Renée T Fortner; Inger T Gram; Patricia Hartge; Annika Idahl; Rudolf Kaaks; Marina Kvaskoff; Anthony M Magliocco; Melissa A Merritt; J Ramón Quirós; Anne Tjonneland; Antonia Trichopoulou; Rosario Tumino; Carla H van Gils; Kala Visvanathan; Nicolas Wentzensen; Anne Zeleniuch-Jacquotte; Shelley S Tworoger
Journal:  Cancer Res       Date:  2019-08-28       Impact factor: 12.701

Review 3.  Association between Cigarette Smoking and Histotype-Specific Epithelial Ovarian Cancer: A Review of Epidemiologic Studies.

Authors:  Aili Zhou; Albina N Minlikeeva; Sadat Khan; Kirsten B Moysich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-01       Impact factor: 4.254

4.  Association between the rs11614913 variant of miRNA-196a-2 and the risk of epithelial ovarian cancer.

Authors:  Zhi-Shuang Song; Yun Wu; Hong-Guo Zhao; Cai-Xia Liu; Hai-Yu Cai; Bao-Zhi Guo; Y A Xie; Hui-Rong Shi
Journal:  Oncol Lett       Date:  2015-11-06       Impact factor: 2.967

5.  Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.

Authors:  Aminah Jatoi; Robert A Vierkant; Kieran M Hawthorne; Matthew S Block; Susan J Ramus; Nicholas B Larson; Brooke L Fridley; Ellen L Goode
Journal:  Oncology       Date:  2016-01-19       Impact factor: 2.935

6.  Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study.

Authors:  Hannah P Yang; Britton Trabert; Megan A Murphy; Mark E Sherman; Joshua N Sampson; Louise A Brinton; Patricia Hartge; Albert Hollenbeck; Yikyung Park; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2011-11-10       Impact factor: 7.396

7.  Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort.

Authors:  Daniel W Cramer; Raina N Fichorova; Kathryn L Terry; Hidemi Yamamoto; Allison F Vitonis; Eva Ardanaz; Dagfinn Aune; Heiner Boeing; Jenny Brändstedt; Marie-Christine Boutron-Ruault; Maria-Dolores Chirlaque; Miren Dorronsoro; Laure Dossus; Eric J Duell; Inger T Gram; Marc Gunter; Louise Hansen; Annika Idahl; Theron Johnson; Kay-Tee Khaw; Vittorio Krogh; Marina Kvaskoff; Amalia Mattiello; Giuseppe Matullo; Melissa A Merritt; Björn Nodin; Philippos Orfanos; N Charlotte Onland-Moret; Domenico Palli; Eleni Peppa; J Ramón Quirós; Maria-Jose Sánchez-Perez; Gianluca Severi; Anne Tjønneland; Ruth C Travis; Antonia Trichopoulou; Rosario Tumino; Elisabete Weiderpass; Renée T Fortner; Rudolf Kaaks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-04-16       Impact factor: 4.254

8.  Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES).

Authors:  Linda E Kelemen; Sarah Abbott; Bo Qin; Lauren Cole Peres; Patricia G Moorman; Kristin Wallace; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa Bondy; Kathleen Cartmell; Michele L Cote; Ellen Funkhouser; Lisa E Paddock; Edward S Peters; Ann G Schwartz; Paul Terry; Anthony J Alberg; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2017-05-02       Impact factor: 2.506

9.  Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort.

Authors:  Mireia Obón-Santacana; Heinz Freisling; Petra H Peeters; Leila Lujan-Barroso; Pietro Ferrari; Marie-Christine Boutron-Ruault; Sylvie Mesrine; Laura Baglietto; Renee Turzanski-Fortner; Verena A Katzke; Heiner Boeing; J Ramón Quirós; Elena Molina-Portillo; Nerea Larrañaga; María-Dolores Chirlaque; Aurelio Barricarte; Kay-Tee Khaw; Nick Wareham; Ruth C Travis; Melissa A Merritt; Marc J Gunter; Antonia Trichopoulou; Pagona Lagiou; Androniki Naska; Domenico Palli; Sabina Sieri; Rosario Tumino; Valentina Fiano; Rocco Galassom; H B As Bueno-de-Mesquita; N Charlotte Onland-Moret; Annika Idahl; Eva Lundin; Elisabete Weiderpass; Hubert Vesper; Elio Riboli; Eric J Duell
Journal:  Int J Cancer       Date:  2015-10-01       Impact factor: 7.396

10.  Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.

Authors:  Mireia Obón-Santacana; Leila Lujan-Barroso; Ruth C Travis; Heinz Freisling; Pietro Ferrari; Gianluca Severi; Laura Baglietto; Marie-Christine Boutron-Ruault; Renée T Fortner; Jennifer Ose; Heiner Boeing; Virginia Menéndez; Emilio Sánchez-Cantalejo; Saioa Chamosa; José María Huerta Castaño; Eva Ardanaz; Kay-Tee Khaw; Nick Wareham; Melissa A Merritt; Marc J Gunter; Antonia Trichopoulou; Eleni-Maria Papatesta; Eleni Klinaki; Calogero Saieva; Giovanna Tagliabue; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H B Bueno-de-Mesquita; Petra H Peeters; N Charlotte Onland-Moret; Annika Idahl; Eva Lundin; Elisabete Weiderpass; Hubert W Vesper; Elio Riboli; Eric J Duell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-23       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.